{"url_path":"/sec/cntx/8-k/2026-06-26/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1842952/0001628280-26-045744-index.html","accession_number":"0001628280-26-045744","cik":"0001842952","ticker":"CNTX","issuer_name":"Context Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1842952/0001628280-26-045744-index.html","primary_entity_key":"0001842952","primary_entity_name":"Context Therapeutics Inc."},"word_count":86,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n3.1\n[Certificate of](cntx-certificateofamendmen.htm)[Amend](cntx-certificateofamendmen.htm)[ment to the Amend](cntx-certificateofamendmen.htm)[ed and Restated Certificate of Incorporation, dated June 24, 2026](cntx-certificateofamendmen.htm)\n\n104Cover Page Interactive Data File (embedded within the inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDated: June 26, 2026Context Therapeutics Inc.\n\nBy: /s/ Martin A. Lehr\n\nName: Martin A. Lehr\n\nTitle: Chief Executive Officer"}